Health Care/Hospital
111, Inc. Announces Third Quarter 2021 Unaudited Financial Results
SHANGHAI, Nov. 19, 2021 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services inChina, today announced its unaudited financial results for the third quart...
2021-11-19 13:31
3784
ASRA 2021 | Cali Biosciences Presents Phase IIa Clinical Data on CPL-01, a Long-Acting Ropivacaine
SAN DIEGO, Nov. 19, 2021 /PRNewswire/ -- Cali Biosciences, a global biopharmaceutical company focused on the research and development of innovative drugs, presented Phase IIa clinical data today on its perioperative long-acting ropivacaine, CPL- 01, at the 20th Annual American Society of Regional...
2021-11-19 13:14
1857
Tavotek Biotherapeutics Announces Completion of Round B Financing with $35 Million
LOWER GWYNEDD, Penn., Nov. 18, 2021 /PRNewswire/ -- Tavotek Biotherapeutics, a fast-growing biotech company, announces it has raised $35M in Round B financing. CS Capital, a leading private equity fund manager in China, led this finance round followed by Fontus Capital. This round of financing wi...
2021-11-19 08:00
2180
Development of "VR hands on training" with hand tracking in live-action medical VR!
TOKYO, Nov. 18, 2021 /PRNewswire/ -- Jolly Good Inc. (Chuo-ku, Tokyo, CEO: Kensuke Joji; "Jolly Good") has developed the "VR hands on training" function as a new feature of the "OPECloud VR hands on training system". This is a VR clinical training platform developed and provided by Jolly Good, wh...
2021-11-18 21:00
2239
Clinical Data Shows the Efficacy of In-Phase and Quadrature Demodulation in Electronic Fetal Heart Rate Monitoring During Labor
SHENZHEN, China, Nov. 18, 2021 /PRNewswire/ -- EDAN Instruments
2021-11-18 15:08
2816
China sees huge bounce in pharma rankings ahead of hybrid CPhI & P-MEC China
SHANGHAI, Nov. 18, 2021 /PRNewswire/ -- China's pharma industry has seen a record improvement in its overall score, growth potential and biologics according to new data. TheChina specific findings of the CPhI Annual Report rankings[1] are released ahead of CPhI & P-MEC China - which will take pla...
2021-11-18 15:00
1657
OncoOne and GenScript ProBio Enter Agreement for the Manufacturing of Monoclonal Antibody Drugs Targeting oxMIF
NANJING, China, Nov. 17, 2021 /PRNewswire/ -- OncoOne
2021-11-17 22:00
2043
Ybrain's Stress Management Solution Pola Named CES 2022 Innovation Award Honoree
PANGYO, South Korea, Nov. 17, 2021 /PRNewswire/ -- Ybrain
https://www.ybrain.com/
2021-11-17 22:00
2410
Inmagene files two international patent applications
SHANGHAI and SAN DIEGO and HANGZHOU, China, Nov. 17, 2021 /PRNewswire/ -- Inmagene Biopharmaceuticals ("Inmagene" or the "Company") announced that it has filed two international patent applications for its drug candidates, IMG-007 (OX40 antagonist) and IMG-008 (IL-36R antagonist). One application...
2021-11-17 18:30
2180
Three Seasons series of 2021 World Young Scientists Summit (WYSS) held at WKU
WENZHOU, China, Nov. 16, 2021 /PRNewswire/ -- On the evening of Nov. 12, Never
Stop at Peak, one of the Science in Three Seasons series of the 2021 World
Young Scientists Summit (WYSS), was held at Wenzhou-Kean University.
2021-11-17 09:53
2088
Terumo Blood and Cell Technologies and Immunicom Establish Agreement to Launch Breakthrough Cancer Immunotherapy Treatment in Europe
* The therapy aims to re-energize a patient's immune system to fight cancer
tumors
* Initial commercialization will target leading oncology centers in Germany,
France, Italy, and Spain LAKEWOOD, Colo. and SAN DIEGO, Nov. 16, 2021
/PRNewswire/ --Terumo Blood and Cell Technologies
2021-11-17 00:00
2338
FibroBiologics Secures $100 Million Capital Commitment from GEM as Company Seeks to Go Public
The Company plans to go public via SPAC, reverse merger, or a direct listing HOUSTON, Nov. 16, 2021 /PRNewswire/ -- FibroBiologics, a clinical stage company developing fibroblast-based therapeutic cures for chronic diseases, announced today that it has signed an agreement with GEM Global Y...
2021-11-16 23:07
1788
82 Percent of Health Systems Reported Experiencing an IoT Cyberattack in Last 18 Months
Medigate & CrowdStrike Promote a Return to Security Infrastructure Fundamentals BROOKLYN, N.Y., Nov. 16, 2021 /PRNewswire/ -- Medigate, healthcare's leading clinical device data security and integration platform, today announced it has launched a research collaboration with CrowdStrike, a leader ...
2021-11-16 22:07
1833
Delivering Health with Science: Huison Virgin DHA at the World Congress of Omega-3 Science & Technology
XIAMEN, China, Nov. 16, 2021 /PRNewswire/ -- The World Congress of Omega-3 Science & Technology, hosted by ISOR, was webcast worldwide onNovember 13 and November 14, 2021. It gathered 28 top experts and heads of relevant industry organizations from around the world who are deeply engaged in Omega...
2021-11-16 21:30
2070
Happiness Development Group Limited Received Nasdaq Notification Letter Regarding Bid Price Deficiency
NANPING, China, Nov. 16, 2021 /PRNewswire/ -- Happiness Development Group Limited ("HAPP" or the "Company"),(NASDAQ: HAPP) announced today that the Company received a notification letter from the Nasdaq Listing Qualifications Staff of The NASDAQ Stock Market LLC ("Nasdaq") onNovember 11, 2021, no...
2021-11-16 21:00
2250
Zepp Health Corporation Reports Third Quarter 2021 Unaudited Financial Results
BEIJING, Nov. 16, 2021 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE: ZEPP) today reported revenue ofRMB1.6 billion (US$249.3 million); GAAP diluted net income per share of RMB0.19 (US$0.03); and GAAP diluted net income per ADS ofRMB0.74 (US$0.11) for the third quarter e...
2021-11-16 18:30
2730
Kazia Therapeutics Appoints John Friend, MD, as Chief Medical Officer
SYDNEY, Nov. 15, 2021 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce the appointment ofJohn Friend, MD, as Chief Medical Officer. In this role, Dr. Friend will be responsible for overseeing the developme...
2021-11-16 00:00
2773
EDAN Revealed Its Blueprint on Speeding Up Clinic Workflow at MEDICA 2021
DUSSELDORF, Germany, Nov. 15, 2021 /PRNewswire/ -- EDAN Instruments, Inc.
2021-11-15 23:15
2975
CARsgen Announces CAR T-cell Product Candidate CT041 Granted PRIME Eligibility by the EMA
SHANGHAI, Nov. 15, 2021 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, today announced that the European Medicines Agency (EMA) has granted Priority M...
2021-11-15 22:10
8282
Validation Study Showcases Success of LSBD's Rapid SARS-CoV-2 Antibody Test
SYDNEY, Nov. 15, 2021 /PRNewswire/ -- The iQ Group Global Ltd (iQG Ltd) (NSX:IQG) on behalf of Life Science Biosensor Diagnostics Pty Ltd (LSBD), has announced the successful completion of a clinical validation study showcasing the efficacy of its rapid SARS-Cov-2 Antibody test. The results of ...
2021-11-15 22:00
2121
Week's Top Stories
Most Reposted
Visa returns as title sponsor for 2026 MAMA AWARDS; Visa Presale registration begins 13 October
[Picked up by 310 media titles]
2026-10-13 10:00
Agoda Partners with Marina Bay Sands on Bespoke Flagship Store for Experience-Led Travel
[Picked up by 277 media titles]
2026-10-08 09:50
New Asia Forum Targets US$30 Billion in Investment into the New Asia at Its Inaugural Edition in Bali
[Picked up by 275 media titles]
2026-10-09 13:21DayOne Upsizes Malaysia Financing to US$7.2 Billion; Total Billings Surpass 1GW and Bookings Reach 2.3GW
[Picked up by 265 media titles]
2026-10-14 18:01Ampotech and Buskowitz Energy Collaborate to Deliver Integrated Energy Solutions Combining Energy Efficiency, Solar and Battery Storage
[Picked up by 262 media titles]
2026-10-14 09:30
Most Read
Nuix Neo Generative AI Framework
2026-10-08 08:02
14455
LEIFRAS Co., Ltd. Reports First Half of Fiscal Year 2026 Financial Results
2026-10-08 09:50
12413
XPENG G9L Completes First Production Trial in Europe
2026-10-08 07:33
11995
